ClinGen is defining the clinical relevance of genes and variants
ClinGen was founded in 2013 by the National Human Genome Research Institute, ClinGen is a growing collaborative effort, involving three grants, nine principal investigators and over 970 contributors from more than 29 countries. Below are a series of recent updates that ClinGen has been working on.
Stakeholder Partnership Forum at Curating the Clinical Genome (CCG) 2019
The ClinGen Stakeholder Partnership WG is hosting a forum to broadly engage our industry stakeholder community towards informing future development of the ClinGen Resource. (Wednesday, May 29th 3:30-5:30 pm)
ClinGen Receives Recognition Through New FDA Human Variant Database Program
The ClinGen expert curated variants are available for unrestricted use in the community via ClinVar.
New to ClinGen? Learn how to get started...
Funded in 2013 by the National Human Genome Research Institute, ClinGen is a growing collaborative effort, involving three grants, nine principal investigators and over 850 contributors from more than 27 countries. Learn more about our efforts by choosing one of the options below.
June 7, 2019
ClinGen Hereditary Hemorrhagic Telangiectasia Variant Curation Expert Panel COI
May 2, 2019
PM3: Recommendation for in trans Criterion PM3 (Version 1.0)
April 30, 2019
ClinGen Publication PolicyThe purpose of the policies established herein is to encourage and facilitate important analyses while providing guidelines that assure appropriate use of any ClinGen Consortium data, timely completion of manuscripts, and adherence to the principles of authorship.
April 26, 2019
Variant Curation Standard Operating Procedure, Version 1
April 26, 2019
Sequence Variant Literature Search Tips and Tricks
April 24, 2019
ClinGen Long QT Syndrome Gene Curation Expert Panel COI